NOMAD POWER SOLUTIONS, INC. Preferred Stock, Shares Outstanding
NOMAD POWER SOLUTIONS, INC. (NMAD) had Preferred Stock, Shares Outstanding of 350.00 thousand shares as of 2018-06-30, per its 10-Q filed 2018-08-02.
Discontinued › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockSharesOutstanding · last filed 2018-08-02
- 2018-06-30: Preferred Stock, Shares Outstanding 350.00K shares.
- 2018-03-31: Preferred Stock, Shares Outstanding 350.00K shares.
- 2017-12-31: Preferred Stock, Shares Outstanding 350.00K shares.
- 2015-03-31: Preferred Stock, Shares Outstanding 175.00K shares.
| Period end | Preferred Stock, Shares Outstanding |
|---|---|
| 2018-06-30 | 350.00K shares 10-Q · filed 2018-08-02 |
| 2018-03-31 | 350.00K shares 10-Q · filed 2018-04-27 |
| 2017-12-31 | 350.00K shares 10-Q · filed 2018-08-02 |
| 2015-03-31 | 175.00K shares 10-Q · filed 2015-05-13 |
| 2014-12-31 | 0.00 shares 10-K · filed 2015-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B |